Gluvilda DM 10/500mg Tablet 10's
Rs. 168.75
Title
Gluvilda DM 10/500mg Tablet 10's
Prescription drug
About: Gluvilda DM 10/500 is a dual antidiabetic tablet used in type 2 diabetes.
Usage Instructions: Typically taken once or twice daily with meals.
Benefits: Improves glycemic control while minimizing hypoglycemia.
How it Works: Likely a DPP‑4 inhibitor (vildagliptin 50 mg ×2 or sitagliptin 50 mg) combined with metformin 500 mg; DPP‑4 inhibition enhances incretin action while metformin reduces hepatic glucose output.
Side Effects: GI upset, headache; rare pancreatitis.
Safety Advice: Monitor renal function and discontinue if pancreatitis suspected.
Storage: Store below 25°C.
Usage Instructions: Typically taken once or twice daily with meals.
Benefits: Improves glycemic control while minimizing hypoglycemia.
How it Works: Likely a DPP‑4 inhibitor (vildagliptin 50 mg ×2 or sitagliptin 50 mg) combined with metformin 500 mg; DPP‑4 inhibition enhances incretin action while metformin reduces hepatic glucose output.
Side Effects: GI upset, headache; rare pancreatitis.
Safety Advice: Monitor renal function and discontinue if pancreatitis suspected.
Storage: Store below 25°C.
₹168.75
MRP: ₹187.50
Save ₹18.75
(10%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Gluvilda DM 10/500 is a dual antidiabetic tablet used in type 2 diabetes.
Usage Instructions: Typically taken once or twice daily with meals.
Benefits: Improves glycemic control while minimizing hypoglycemia.
How it Works: Likely a DPP‑4 inhibitor (vildagliptin 50 mg ×2 or sitagliptin 50 mg) combined with metformin 500 mg; DPP‑4 inhibition enhances incretin action while metformin reduces hepatic glucose output.
Side Effects: GI upset, headache; rare pancreatitis.
Safety Advice: Monitor renal function and discontinue if pancreatitis suspected.
Storage: Store below 25°C.
Usage Instructions: Typically taken once or twice daily with meals.
Benefits: Improves glycemic control while minimizing hypoglycemia.
How it Works: Likely a DPP‑4 inhibitor (vildagliptin 50 mg ×2 or sitagliptin 50 mg) combined with metformin 500 mg; DPP‑4 inhibition enhances incretin action while metformin reduces hepatic glucose output.
Side Effects: GI upset, headache; rare pancreatitis.
Safety Advice: Monitor renal function and discontinue if pancreatitis suspected.
Storage: Store below 25°C.